SENTINELONE INC -CLASS A (S)

US81730H1095 - Common Stock

21.7  +0.14 (+0.65%)

After market: 21.59 -0.11 (-0.51%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to S. S was compared to 276 industry peers in the Software industry. S has a great financial health rating, but its profitability evaluates not so good. S is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

S had negative earnings in the past year.
In the past year S has reported a negative cash flow from operations.
In the past 5 years S always reported negative net income.
S had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

S has a Return On Assets (-14.59%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -21.25%, S is in line with its industry, outperforming 48.54% of the companies in the same industry.
Industry RankSector Rank
ROA -14.59%
ROE -21.25%
ROIC N/A
ROA(3y)-14.88%
ROA(5y)-27.06%
ROE(3y)-20.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

S has a better Gross Margin (71.14%) than 60.95% of its industry peers.
In the last couple of years the Gross Margin of S has grown nicely.
S does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.24%
GM growth 5Y3.94%

8

2. Health

2.1 Basic Checks

S does not have a ROIC to compare to the WACC, probably because it is not profitable.
S has more shares outstanding than it did 1 year ago.
S has less shares outstanding than it did 5 years ago.
There is no outstanding debt for S. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 4.81 indicates that S is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.81, S is doing good in the industry, outperforming 69.71% of the companies in the same industry.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.81
ROIC/WACCN/A
WACC9.99%

2.3 Liquidity

S has a Current Ratio of 2.20. This indicates that S is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.20, S is in the better half of the industry, outperforming 63.87% of the companies in the same industry.
S has a Quick Ratio of 2.20. This indicates that S is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of S (2.20) is better than 64.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.00% over the past year.
Looking at the last year, S shows a very strong growth in Revenue. The Revenue has grown by 47.12%.
Measured over the past years, S shows a very negative growth in Revenue. The Revenue has been decreasing by -54.66% on average per year.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q84.62%
Revenue 1Y (TTM)47.12%
Revenue growth 3Y88.26%
Revenue growth 5Y-54.66%
Revenue growth Q2Q38.12%

3.2 Future

S is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.48% yearly.
Based on estimates for the next years, S will show a very strong growth in Revenue. The Revenue will grow by 30.49% on average per year.
EPS Next Y108.97%
EPS Next 2Y72.16%
EPS Next 3Y56.71%
EPS Next 5Y49.49%
Revenue Next Year32.56%
Revenue Next 2Y30.42%
Revenue Next 3Y29.28%
Revenue Next 5Y30.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for S. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 863.76, S can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of S is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of S to the average of the S&P500 Index (21.32), we can say S is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 863.76

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
S's earnings are expected to grow with 56.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.16%
EPS Next 3Y56.71%

0

5. Dividend

5.1 Amount

No dividends for S!.
Industry RankSector Rank
Dividend Yield N/A

SENTINELONE INC -CLASS A

NYSE:S (4/29/2024, 7:24:52 PM)

After market: 21.59 -0.11 (-0.51%)

21.7

+0.14 (+0.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.73B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 863.76
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.59%
ROE -21.25%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 71.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y108.97%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)47.12%
Revenue growth 3Y88.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y